Eli Lilly Ready to Seek Obesity Pill Green Light After Study Hits Goals

[WSJ.com: Health]

Eli Lilly said a third late-stage study of its experimental anti-obesity pill hit its key goals, paving the way for the drugmaker to begin regulatory submissions.

Continue reading...

 

Join 𝕋𝕄𝕋 on Telegram
Channel PREVIEW: